The eubiotics market is expected to register significant growth by 2027 due to rising prevalence of livestock diseases worldwide.

Eubiotics are a type of feed additive added to animal feed to ensure gut integrity in livestock. This class of feed additives includes organic acids, probiotics, essential oils, prebiotics, and polyphenols. The ongoing shift towards maintaining the healthy functioning of the digestive system of animals under commercial production without using antibiotics has boosted industry uptake in recent years.

Moreover, recent studies indicate that the use of eubiotic feed additives into milk replacer has been shown to improve dairy calves’ rumen fermentation, health, biochemical blood indicators, and performance during the preweaning period. Recently, mounting demand for animal products, such as meat, milk, and eggs, has fostered market expansion.

The eubiotics market has been bifurcated based on livestock, product, application, form, and region. In terms of product, the market has further been divided into exogenous enzymes, prebiotics, essential oils, probiotics, and organic acid. Under prebiotics, the market has been categorized into galacto-oligosaccharide (GOS), inulin, fructo-oligosaccharide (FOS), mannan-oligosaccharide (MOS), and others.

The inulin segment is set to register over 10.0% gains by the end of 2027. The fructo-oligosaccharide (FOS) segment is projected to expand at a CAGR of above 10.3% over the forecast period. The mannan-oligosaccharide (MOS) segment is speculated to grow at approximately 10.5% CAGR through the stipulated period. Meanwhile, the galacto-oligosaccharide (GOS) segment is expected to reach a valuation of about USD 21.5 million by the end of 2027.

The probiotics segment is estimated to surpass USD 450 million in revenue by 2027 on account of mounting adoption of probiotics in poultry and swine nutrition. Under probiotics, the market has been segmented into Streptococcus, Lactobacillus, Bacillus, Bifidobacterium, and others.

The Lactobacillus segment is expected to attain a valuation of around USD 305 million by the end of 2027. The Bifidobacterium segment is calculated to register 7.3% gains by 2027. The Bacillus segment is speculated to progress at about 8.8% CAGR over the analysis timeframe. Meanwhile, the Streptococcus segment is slated to garner above 9.0% gains by 2027.

Under organic acids, the market has further been classified into propionic acid, acetic acid, formic acid, lactic acid, fumaric acid, and others. In 2020, the acetic acid segment accounted for about 3% market share and is projected to grow at a steady pace over 2021-2027. The lactic acid segment is anticipated to exhibit notable growth at approximately 8.9% CAGR through the study timeline.

The essential oils segment is poised to exceed a valuation USD 465 million by the end of 2027. Prevalent use of natural ingredients in animal feed products is slated to bolster segmental development in the forthcoming years.

Under exogenous enzymes, the market has been segregated into ??-glucanase, amylase, protease, xylanases, and phytase. The xylanases segment is likely to be worth more than USD 285 million in revenue by 2027. The ??-glucanase segment is slated to witness robust growth at a CAGR of around 10.4% over the assessment period.

From the application spectrum, the eubiotics market has been segregated into immunity, gut health, yield, and others. The others application segment is expected to grow at nearly 7.0% CAGR over the forecast period. Eubiotics help in balancing microflora in the gastrointestinal tract of the livestock, which promotes the growth performance of animals.

With respect to livestock, the eubiotics market has been bifurcated into aquaculture, poultry, cattle, swine, and others. The aquaculture segment is anticipated to be valued at over USD 300 million by 2027 due to the booming aquaculture industry in China, India, and Japan, among others. The others livestock segment is speculated to garner a valuation of around USD 860 million by 2027 owing to increasing focus towards improving the overall health and growth performance of animals. Other livestock include sheep and horses.

From the regional perspective, the Latin America eubiotics market is set to exceed a valuation of USD 860 million by 2027 on account of growing livestock farming and meat export in Brazil. The Middle East and Africa eubiotics industry is projected to expand at a CAGR of approximately 9.0% through the review period driven by surging demand for high-quality meat and meat products in the MEA region.